Clinical Characteristics of Patients with Different N-Terminal Probrain Natriuretic Peptide Levels after Hematopoietic Stem Cell Transplantation

Table 1

Patient characteristics.

Variables	Total ()	ENPH ()	ENAH ()	NN ()	value
Age (years)					0.893
Female	121 (40.2)	32 (46.4)	70 (42.7)	19 (27.9)	0.056
BMI (kg/m^2)					0.237
Haemodynamics
Systolic BP (mmHg)					0.958
Diastolic BP (mmHg)					0.985
Heart rate (beats/min)					0.740
LVEF (%)					0.633
LVEDD (mm)					0.827
Laboratory values
Sodium (mEq/L)					0.149
Uric acid (mg/dL)					0.011
eGFR (mL/min/1.73m^2)					0.159
NT-proBNP (pg/mL) (baseline)	55.0 (30.0, 112.0)	70.0 (31.0, 119.0)	59.0 (37.25, 119.0)	33.50 (23.8, 55.0)	<0.001
NT-proBNP (pg/mL) (post-HSCT)	415.0 (141.0, 1283.0)	1055.0 (374.0, 5155.0)	538.5 (254.5, 1366.0)	55.0 (38.0, 81.3)	<0.001
Hemoglobin (g/dL)					<0.001

Values are , (%), or median (interquartile range). ENPH: elevated NT-proBNP and presence of clinical signs or symptoms of heart failure; ENAH: elevated NT-proBNP but absence of symptoms or signs of heart failure; NN: normal NT-proBNP; BMI: body mass index; BP: blood pressure; LVEF: left ventricle ejection fraction; LVEDD: left ventricular end-diastolic diameter; eGFR: estimated glomerular filtration rate; NT-proBNP: N-terminal probrain natriuretic peptide.